ADC Therapeutics (ADCT) Return on Assets (2021 - 2026)

ADC Therapeutics (ADCT) has reported Return on Assets for 6 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.

• Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2022 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Assets advanced to 0.0% in Q1 2026 per ADCT's latest filing, from 0.0% in the prior quarter.
• Over the last five years, Return on Assets for ADCT reached as high as 0.0% in Q4 2022 and fell as low as 0.0% in Q2 2025.
• A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Assets.
• The largest YoY upside for Return on Assets was 0 bps in 2022 against a maximum downside of 0 bps in 2022.
• Year by year, Return on Assets stood at 0.0% in 2022, then fell by 27 bps to 0.0% in 2023, then fell by 1 bps to 0.0% in 2024, then fell by 19 bps to 0.0% in 2025, then climbed by 4 bps to 0.0% in 2026.
• According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.